Crossmark

Role of telitacicept in the treatment of IgA nephropathy

Crossref DOI link: https://doi.org/10.1186/s40001-023-01320-2

Published Online: 2023-09-22

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Lijun https://orcid.org/0000-0002-3813-822X
Du, Xinru

Lu, Xuehong
License Information

Text and Data Mining valid from 2023-09-22

Version of Record valid from 2023-09-22
More Information

Article History

Received: 10 April 2023

Accepted: 27 August 2023

First Online: 22 September 2023

Declarations

:

: Not applicable.

: Not applicable.

: Authors confirm that there are no competing interests.